Features of Memory-Like and PD-1(+) Human NK Cell Subsets.
Human NK cells are distinguished into CD56(bright)CD16(-) cells and CD56(dim)CD16(+) cells. These two subsets are conventionally associated with differential functional outcomes and are heterogeneous with respect to the expression of KIR and CD94/NKG2 heterodimers that represent the two major types of HLA-class I-specific receptors. Recent studies indicated that immature CD56(bright) NK cells, homogeneously expressing the inhibitory CD94/NKG2A receptor, are precursors of CD56(dim) NK cells that, in turn, during their process of differentiation, lose expression of CD94/NKG2A and subsequentially acquire inhibitory KIRs and LIR-1. The terminally differentiated phenotype of CD56(dim) cells is marked by the expression of the CD57 molecule that is associated with poor responsiveness to cytokine stimulation, but retained cytolytic capacity. Remarkably, this NKG2A(-)KIR(+)LIR-1(+)CD57(+)CD56(dim) NK cell subset when derived from individuals previously exposed to pathogens, such as human cytomegalovirus (HCMV), may contain "memory-like" NK cells. These cells are generally characterized by an upregulation of the activating receptor CD94/NKG2C and a downregulation of the inhibitory receptor Siglec-7. The "memory-like" NK cells are persistent over time and display some hallmarks of adaptive immunity, i.e., clonal expansion, more effective antitumor and antiviral immune responses, longevity, as well as given epigenetic modifications. Interestingly, unknown cofactors associated with HCMV infection may induce the onset of a recently identified fully mature NK cell subset, characterized by marked downregulation of the activating receptors NKp30 and NKp46 and by the unexpected expression of the inhibitory PD-1 receptor. This phenotype correlates with an impaired antitumor NK cell activity that can be partially restored by antibody-mediated disruption of PD-1/PD-L interaction.
Dipartimento di Medicina Sperimentale, Università degli Studi di Genova , Genova , Italy.
Mariella
M
Della Chiesa
Dipartimento di Medicina Sperimentale, Università degli Studi di Genova , Genova , Italy.
Silvia
S
Pesce
Dipartimento di Medicina Sperimentale, Università degli Studi di Genova , Genova , Italy.
Letizia
L
Muccio
Dipartimento di Medicina Sperimentale, Università degli Studi di Genova , Genova , Italy.
Simona
S
Carlomagno
Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genova, Italy; CEBR, Università degli Studi di Genova, Genova, Italy.
Simona
S
Sivori
Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genova, Italy; CEBR, Università degli Studi di Genova, Genova, Italy.
Alessandro
A
Moretta
Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genova, Italy; CEBR, Università degli Studi di Genova, Genova, Italy.
Emanuela
E
Marcenaro
CD57; HCMV; NKG2C; PD-1; human NK cells; immune checkpoint; memory
Haematologica. 2016 Mar;101(3):371-81
26659918
J Viral Hepat. 2010 Jul;17(7):453-8
20487259
J Immunol. 2009 Nov 15;183(10):6612-8
19846870
J Leukoc Biol. 2002 Feb;71(2):173-83
11818437
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32
21825173
Cell Death Differ. 2008 Feb;15(2):226-33
17541426
Blood. 2007 May 1;109(9):3625-32
17202316
Cell Rep. 2016 May 3;15(5):1088-99
27117418
Eur J Immunol. 2012 Feb;42(2):541-50
22105417
Cancer Cell. 2015 Apr 13;27(4):450-61
25858804
J Exp Med. 1995 Sep 1;182(3):875-84
7650491
Blood. 2010 Nov 11;116(19):3853-64
20696944
J Exp Med. 2009 Jul 6;206(7):1495-503
19528259
Blood. 2004 Dec 1;104(12):3664-71
15304389
J Allergy Clin Immunol. 2017 Jan;139(1):335-346.e3
27372564
J Infect Dis. 2010 Aug 15;202(4):524-32
20617899
Int Arch Allergy Immunol. 2014;164(4):253-64
25323661
Immunotherapy. 2011 Sep;3(9):1075-86
21913830
Nat Rev Immunol. 2005 Mar;5(3):201-14
15719024
J Clin Oncol. 2015 Dec 1;33(34):4015-22
26351349
J Immunol. 2016 May 1;196(9):3818-27
26994220
N Engl J Med. 2012 Jun 28;366(26):2443-54
22658127
Front Immunol. 2014 Aug 14;5:390
25177322
Int Immunol. 1999 Jan;11(1):29-35
10050671
Immunity. 2015 Mar 17;42(3):443-56
25786176
Nature. 1998 Feb 19;391(6669):795-9
9486650
Clin Immunol. 2008 Jul;128(1):46-56
18495540
PLoS Pathog. 2014 Oct 16;10(10):e1004441
25329659
Blood. 2010 Nov 11;116(19):3865-74
20733159
Blood. 2009 Nov 5;114(19):4108-16
19749090
J Immunol. 2012 Nov 15;189(10):5082-8
23077239
Annu Rev Immunol. 1996;14:619-48
8717527
Int Immunol. 2010 Aug;22(8):651-60
20587542
Blood. 2010 Sep 30;116(13):2286-94
20460501
J Exp Med. 2005 Oct 3;202(7):941-53
16203865
Oncoimmunology. 2015 Jan 22;4(4):e1001224
26137398
Int Immunol. 2012 Dec;24(12):793-802
22962434
Cancer Med. 2013 Oct;2(5):662-73
24403232
Nature. 2006 Feb 9;439(7077):682-7
16382236
Biol Blood Marrow Transplant. 2010 May;16(5):612-21
20139023
Eur J Immunol. 1999 May;29(5):1656-66
10359120
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2886-91
15699323
J Immunol. 2015 Mar 15;194(6):2715-24
25667418
Blood. 2006 May 1;107(9):3624-31
16384928
Immunol Today. 1997 Jun;18(6):286-91
9190115
Trends Immunol. 2010 Nov;31(11):401-6
20829113
Nature. 2006 Sep 21;443(7109):350-4
16921384
J Exp Med. 2011 Jan 17;208(1):13-21
21173105
Annu Rev Immunol. 2008;26:677-704
18173375
Cancer Immunol Res. 2014 Apr;2(4):320-31
24764579
Trends Immunol. 2016 Mar;37(3):233-43
26869205
Blood. 2012 Mar 15;119(11):2665-74
22180440
Semin Immunol. 2014 Apr;26(2):114-26
24594002
Blood. 2012 Nov 22;120(22):4317-23
23002117
Viral Immunol. 2012 Aug;25(4):329-32
22742708
Trends Immunol. 2001 Nov;22(11):633-40
11698225
Blood. 2009 Sep 24;114(13):2667-77
19553639
Case Rep Oncol. 2014 Jan 24;7(1):70-8
24575020
Nat Immunol. 2013 Dec;14(12):1212-8
24240160
Blood. 2010 Mar 18;115(11):2167-76
19965656
Blood. 2013 Apr 25;121(17):3396-401
23449637
Immunity. 2015 Mar 17;42(3):431-42
25786175
BMC Gastroenterol. 2012 Aug 16;12:109
22894700
J Neuroimmunol. 2006 Oct;179(1-2):117-25
16904757
Blood. 2013 Apr 4;121(14):2678-88
23325834
J Immunol Res. 2015;2015:754373
25961063
Blood. 2014 Jan 30;123(5):678-86
24326534
Blood. 2012 Jan 12;119(2):399-410
22096237
Front Immunol. 2015 Nov 09;6:573
26617607
Leukemia. 2016 Feb;30(2):456-63
26416461
J Immunol. 2014 Feb 15;192(4):1471-9
24442432
Annu Rev Immunol. 2001;19:197-223
11244035
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):728-32
21187373